Ledger.Open graph →
SEC Form D · filed March 17, 2026

Strand Therapeutics Inc

Offering
$120.1M
Sold
$108.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Jeb Keiper · Boston, MADirectorAla Alenazi · Boston, MADirectorPegah Ebrahimi · Wilson, WYDirectorTasuku Kitada · Boston, MAExec · Director · PromoterSamta Kundu · Boston, MAExecJory Bell · Boston, MADirectorJacob Becraft · Boston, MAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗